Behold, the power of May ensued! Recover with the latest in Patient Recruitment and Retention News!
The Cost of Non-Adherence in Clinical Trials: A Perfect Use Case for SMS Medication Reminders
The costs of clinical trial non-adherence are far from just financial, and the smallest increase in study participant adherence goes far. Text messaging is an extremely direct and efficient way to engage study patients. Along with the utilization of a medication adherence reminder app, text messaging can be a huge asset for clinical trials that rely on adherence to protocol.
Trending PR+R News
Non-Adherence: A Direct Influence on Clinical Trial Duration and Cost
The biopharmaceutical industry is overlooking one critical element that affects study timelines: patient non-adherence. As noted in the Mosio exclusive article, this article aptly reviews clinical trial costs, the impact of non-adherence on study duration, and the cost of non-adherence.
3 Protocol Design Strategies To Enhance Patient Recruitment
Getting patients to enroll in clinical trials comes down to two things: making the trial more patient-centric, and being transparent about the trial and its objectives. The focus of this article is on tangible, workable strategies that companies of all sizes can implement in the short term to realize their clinical development objectives and deliver therapies to patients in a timely manner.
Text Messaging and Mobile Phone Apps as Interventions to Improve Adherence in Adolescents With Chronic Health Conditions (CHCs): A Systematic Review
Medication non-adherence is a global challenge among adolescents across chronic conditions and is associated with poor health outcomes. The purpose of this review was to systematically evaluate the most recent evidence for the efficacy of text messaging and mobile phone apps as interventions for this particular popluation. Investigators found the use of text messaging and mobile phone app interventions to improve medication adherence among adolescents with CHCs has shown promising feasibility and acceptability, and there is modest evidence to support the efficacy of these interventions.
Best and Worst Digital Campaigns for Patient Recruitment
The most successful campaigns position the digital campaign as an essential element and begin communicating the plan to sites early and send updates frequently. If considering digital recruitment tactics for your next clinical trial, pay careful attention to both the strategy and execution. When both are done well, it will ensure success.
Challenges in Patient Recruitment: How to Prevent Under-Enrolling Clinical Trials
Predicting enrollment is not as simple as gazing into a crystal ball; it can be quite unpredictable. Nevertheless, if sites and sponsors work to help one another, accurately planning for and achieving patient enrollment goals in clinical trials can become a reality. Read more for details on how to prevent under-enrollment.
Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: A randomized clinical trial
Adherence to treatment remains the cornerstone of long term viral suppression and successful treatment outcomes among patients receiving Antiretroviral Therapy (ART). Researchers evaluated the effectiveness of mobile phone reminders and peer counseling in improving adherence and treatment outcomes among HIV positive patients on ART in Malaysia. Results showed the response rate after 6 months follow up was 93%, with the mean adherence significantly higher in the intervention group as compared to the control group.
Patient Advocacy in Clinical Research
The Rare Diseases Clinical Research Network (RDCRN), part of the NIH, has expanded its research efforts to include collaboration with representatives of 98 patient advocacy groups to advance clinical research and investigate new treatments for patients with rare diseases. The RDCRN is designed to advance medical research on rare diseases by providing support for clinical studies and facilitating collaboration, study enrollment and data sharing. Through the RDCRN consortia, 94% of principal investigators are involved in patient recruitment, and 89% of the PAG’s are involved in patient recruitment.